Hitre E - Search Results

1

[Modern pharmacological therapy of breast cancer].

Láng I, Kahán Z, Hitre E, Dank M, Rubovszky G, Horváth Z, Kásler M. Láng I, et al. Among authors: hitre e. Orv Hetil. 2012 Jan 15;153(2):56-65. doi: 10.1556/OH.2012.29257. Orv Hetil. 2012. PMID: 22217685 Review. Hungarian.

2

Case 3. Resection of originally inoperable liver metastases of gastrointestinal stromal tumor after imatinib mesylate therapy.

Láng I, Hitre E, Horváth Z, Godény M. Láng I, et al. Among authors: hitre e. J Clin Oncol. 2003 Sep 15;21(18):3538-40. doi: 10.1200/JCO.2003.03.176. J Clin Oncol. 2003. PMID: 12972533 No abstract available.

3

[The clinical importance of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in the 5-fluoropyrimidine-based therapy of metastatic colorectal tumours].

Budai B, Hitre E, Adleff V, Czeglédi F, Gyergyay F, Láng I, Kralovánszky J. Budai B, et al. Among authors: hitre e. Magy Onkol. 2004;48(3):253-7. Epub 2004 Nov 1. Magy Onkol. 2004. PMID: 15520876 Free article. Hungarian.

4

[Recent results of irinotecan therapy in colorectal cancer].

Láng I, Hitre E. Láng I, et al. Among authors: hitre e. Magy Onkol. 2004;48(4):281-8. Epub 2005 Jan 17. Magy Onkol. 2004. PMID: 15655572 Free article. Review. Hungarian.

5

[Current aspects of treatment in gastrointestinal stromal tumors (GIST)].

Láng I, Hitre E. Láng I, et al. Among authors: hitre e. Orv Hetil. 2005 May 1;146(18 Suppl 1):935-41. Orv Hetil. 2005. PMID: 15921308 Review. Hungarian.

6

Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil.

Hitre E, Budai B, Adleff V, Czeglédi F, Horváth Z, Gyergyay F, Lövey J, Kovács T, Orosz Z, Láng I, Kásler M, Kralovánszky J. Hitre E, et al. Pharmacogenet Genomics. 2005 Oct;15(10):723-30. doi: 10.1097/01.fpc.0000175598.42141.59. Pharmacogenet Genomics. 2005. PMID: 16141798

7

[The feasibility and the role of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].

Péley G, Török K, Farkas E, Mátrai Z, Horváth Z, Sinkovics I, Hitre E, Rényi-Vámos F, Orosz Z, Köves I. Péley G, et al. Among authors: hitre e. Magy Onkol. 2006;50(1):19-23. Epub 2006 Apr 17. Magy Onkol. 2006. PMID: 16617379 Free article. Hungarian.

8

[Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].

Mátrai Z, Lövey J, Hitre E, Orosz Z, Gödény M, Péley G, Sulyok Z, Rényi Vámos F, Farkas E, Köves I. Mátrai Z, et al. Among authors: hitre e. Orv Hetil. 2006 Oct 22;147(42):2011-20. Orv Hetil. 2006. PMID: 17165600 Review. Hungarian.

9

[Trastuzumab (Herceptin) in the adjuvant treatment of HER-2-positive early breast cancer].

Láng I, Hitre E. Láng I, et al. Among authors: hitre e. Magy Onkol. 2006;50(4):293-302. Epub 2007 Jan 10. Magy Onkol. 2006. PMID: 17216002 Free article. Hungarian.

10

[Changes in renal function during bisphosphonate treatment of breast cancer patients].

Horváth Z, Farkas P, Ganofszky E, Hitre E, Juhos E, Nagy T, Rubovszky G, Szabó E, Láng I. Horváth Z, et al. Among authors: hitre e. Magy Onkol. 2008 Mar;52(1):49-55. doi: 10.1556/MOnkol.52.2008.1.7. Magy Onkol. 2008. PMID: 18403297 Hungarian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters